Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Synergistic effect of Ceftriaxone and diclofenac against Escherichia Coli

View through CrossRef
Background: The emergence of resistant strains of bacteria has rendered many useful antibiotics ineffective. The researchers areforced to try combination of two or more antibiotics, or addition of a non- antibacterial to them. Ceftriaxone, a third-generationcephalosporin agent is used to treat many infectious diseases, especially those caused by members of Enterobacteriaceae family.We tested the efficacy of ceftriaxone, alone and in combination with various concentrations of diclofenac sodium, againstEscherichia coli.Objective: To study the synergistic effect of ceftriaxone and its combination with non-antibiotic drug diclofenac sodium againstEscherichia coli ATCC 25922 isolate.Material and Methods: Agar well diffusion technique was applied. 30 µl of solutions of ceftriaxone, and its combination withdifferent concentrations of diclofenac sodium and DMSO were transferred aseptically into the wells. Agar plates were placed in incubator at 37°C for 24 hours. Mean zone of inhibition of each drug was calculated.Results: Ceftriaxone 30µg formed a zone of inhibition of 35 mm. Its combination with 25µg and 50µg of diclofenac sodium formedzone of inhibition of 37.5mm while its combination with 100µg diclofenac sodium formed a zone of inhibition of 38.6mm and formed39.8mm zone of inhibition when combined with 200µg diclofenac sodium.Conclusion: Ceftriaxone activity increased when combined with different concentrations of diclofenac sodium drug showing asynergistic effect of their combination.Key words: ceftriaxone, Diclofenac sodium, E. coli, Synergism
Title: Synergistic effect of Ceftriaxone and diclofenac against Escherichia Coli
Description:
Background: The emergence of resistant strains of bacteria has rendered many useful antibiotics ineffective.
The researchers areforced to try combination of two or more antibiotics, or addition of a non- antibacterial to them.
Ceftriaxone, a third-generationcephalosporin agent is used to treat many infectious diseases, especially those caused by members of Enterobacteriaceae family.
We tested the efficacy of ceftriaxone, alone and in combination with various concentrations of diclofenac sodium, againstEscherichia coli.
Objective: To study the synergistic effect of ceftriaxone and its combination with non-antibiotic drug diclofenac sodium againstEscherichia coli ATCC 25922 isolate.
Material and Methods: Agar well diffusion technique was applied.
30 µl of solutions of ceftriaxone, and its combination withdifferent concentrations of diclofenac sodium and DMSO were transferred aseptically into the wells.
Agar plates were placed in incubator at 37°C for 24 hours.
Mean zone of inhibition of each drug was calculated.
Results: Ceftriaxone 30µg formed a zone of inhibition of 35 mm.
Its combination with 25µg and 50µg of diclofenac sodium formedzone of inhibition of 37.
5mm while its combination with 100µg diclofenac sodium formed a zone of inhibition of 38.
6mm and formed39.
8mm zone of inhibition when combined with 200µg diclofenac sodium.
Conclusion: Ceftriaxone activity increased when combined with different concentrations of diclofenac sodium drug showing asynergistic effect of their combination.
Key words: ceftriaxone, Diclofenac sodium, E.
coli, Synergism.

Related Results

Barriers to accessibility of ceftriaxone among adult postoperative patients at Mulago National Referral Hospital, Uganda
Barriers to accessibility of ceftriaxone among adult postoperative patients at Mulago National Referral Hospital, Uganda
Abstract Background: Access to ceftriaxone is still low, causing 11% of patients not to complete their treatment at health facilities in Uganda; which could increase antimi...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract Introduction Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Resveratrol mitigates diclofenac‐induced hepatorenal toxicity in rats via modulation of miR‐144/Nrf2/GSH axis
Resveratrol mitigates diclofenac‐induced hepatorenal toxicity in rats via modulation of miR‐144/Nrf2/GSH axis
AbstractDespite the extensive therapeutic uses of diclofenac, it may cause several adverse effects, including hepatorenal injury. The antioxidant and anti‐inflammatory properties o...
Pathological and Ameliorative Effect of Curcumin Against Toxic Effect of Diclofenac Sodium In The Rabbits
Pathological and Ameliorative Effect of Curcumin Against Toxic Effect of Diclofenac Sodium In The Rabbits
Background: Diclofenac sodium is a commonly prescribed non-steroidal anti-inflammatory drug (NSAID), valued for its analgesic and anti-inflammatory efficacy. However, its long-term...
Clinical Pharmacology of Ceftriaxone
Clinical Pharmacology of Ceftriaxone
Ceftriaxone is a third-generation cephalosporin and is resistant to many narrow-spectrum β-lactamases and has good activity against most gram-positive and gram-negative aerobic bac...
Oral versus Rectal Diclofenac Sodium: Comparison of efficacy for Perineal pain relief after Episiotomy
Oral versus Rectal Diclofenac Sodium: Comparison of efficacy for Perineal pain relief after Episiotomy
Objective: To compare the efficacy of oral diclofenac sodium and diclofenac suppository for perineal pain relief after episiotomy. Study Design: Prospective randomized clinical tri...
Diarrhoeagenic Escherichia coli isolated from children with acute diarrhoea at Rakai hospital, Southern Uganda
Diarrhoeagenic Escherichia coli isolated from children with acute diarrhoea at Rakai hospital, Southern Uganda
Background: Diarrhoeagenic Escherichia coli (DEC) is a leading cause of childhood diarrhoea. This study estimated the prevalence of DEC and DEC pathotypes among children with acute...

Back to Top